Goldman Sachs Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Goldman Sachs analyst Richard Felton maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €40.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Felton covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care AG & Co. KGaA, GN Store Nord, and Demant. According to TipRanks, Felton has an average return of 4.8% and a 55.08% success rate on recommended stocks.
In addition to Goldman Sachs, Fresenius Medical Care AG & Co. KGaA also received a Hold from Barclays’s Hassan Al-Wakeel in a report issued today. However, on the same day, Jefferies maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).
The company has a one-year high of €54.02 and a one-year low of €35.67. Currently, Fresenius Medical Care AG & Co. KGaA has an average volume of 876.3K.
Read More on GB:0H9X:
Disclaimer & DisclosureReport an Issue
- 0H9X Earnings this Week: How Will it Perform?
- Fresenius Medical price target lowered to EUR 36 from EUR 37 at Morgan Stanley
- Fresenius Medical price target lowered to EUR 44 from EUR 46 at Deutsche Bank
- Weak Operating Momentum, Limited Earnings Visibility, and 2026 Headwinds Drive Underperform (Sell) Rating and Price Target Cut to €32
- Fresenius Medical price target lowered to EUR 39.50 from EUR 48.50 at Citi
